Granules India gets USFDA nod for generic drug

Granules Pharmaceuticals, Inc. secured USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets. The tablets treat ADHD in children and adults. They also treat binge eating disorder in adults. The drug is available in various strengths. This approval addresses drug shortages. Granules India's chairman emphasized their commitment to patient needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uGsQtPk
via IFTTT